Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net loss	$ (455,131)	$ (708,387)
Adjustments to reconcile net (loss) to net cash (used in) operating activities:
Amortization of patent costs	0	32,235
Loss from equity in other ventures	431	366
Changes in assets and liabilities:
Increase in prepaid and other assets	(69,418)	(14,385)
Decrease in escrow deposits	0	110,000
Increase in real estate held for development	(1,801,146)	(29,917,249)
Increase in accrued expenses and other liabilities	238,001	157,668
Net cash used in operating activities	(2,087,263)	(30,339,752)
Financing activities:
Capital contributed by shareholder	0	635,900
Sale of common stock less registration costs	0	19,847,089
Net cash provided by financing activities	0	20,482,989
Net decrease in cash and cash equivalents	(2,087,263)	(9,856,763)
Cash and cash equivalents - beginning of period	11,877,951	22,134,451
Cash and cash equivalents - end of period	$ 9,790,688	$ 12,277,688